Xiao-Fang Li

Dr. Xiao-Fang Li


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2016 in Journal of Proteome Research
Verified
Journal Article
Closed access
XZXiaowei Zhou
Xiaowei Zhou
GQGuanyu Qian
Guanyu Qian
XYXingling Yi
Xingling Yi
XLXiao-Fang Li
Xiao-Fang Li
WLWeida Liu
Weida Liu

13 June 2022 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
YHYun He
Yun He
HZHai-Lin Zheng
Hai-Lin Zheng
HMHuan Mei
Huan Mei
GLGui-Xia Lv
Gui-Xia Lv
WLWei-Da Liu
Wei-Da Liu
XLXiao-Fang Li
Xiao-Fang Li
Background: Due to more attentions paid to melanized fungi over the past few decades and under the background of the global coronavirus disease 2019 pandemic (COVID-19) the fact that the virus itself and the immunosuppressive agents such as glucocorticoids can further increase the risk of infections of deep mycoses, the number of patients with phaeohyphomycosis (PHM) has a substantial increase. Their spectrum is broad and the early diagnosis and treatments are extremely sticky. This study aims to more comprehensively understand the clinical features of phaeohyphomycosis in China over 35 years and to establish a more applicable systematical classification and severity grades of lesions to guide treatments and prognosis.Methods: We reviewed 174 cases of proven phaeohyphomycosis reported in Chinese and English language literature from 1987 to 2021 and we also made the accurate classification definitions and detailed information about the epidemiology, species of clinical dematiaceous fungi, minimum inhibitory concentration values, clinical features, treatments, and prognosis.Results: The mortality of cerebral, disseminated and pulmonary phaeohyphomycosis are 55%, 36%, and 25%. Nearly 19% of patients had poor quality of life caused by the complications such as disability, disfigurements, and blindness. The overall misdiagnosis rate of phaeohyphomycosis was 74%. Moderate to severe rashes are accounting for 82% of subcutaneous phaeohyphomycosis. The areas of the head and face are mostly affected accounting for 16% of severe rashes. Nearly 30% of invasive infections of phaeohyphomycosis are triggered by recurrent lesions. Voriconazole, itraconazole, amphotericin B deoxycholate (AmB-DOC), and terbinafine were most commonly used but diagnosis and treatments of phaeohyphomycosis remain challenging in reality.Conclusions: Our classifications are likely to be more practical and easier to popularize, and there are still also plenty of characteristics in these non-specific lesions. There’re no significant variations in cure rates, or death rates between three grades of lesions. But patients with severe rashes have longer courses and lower effective rates.

21 September 2016 in Journal of Proteome Research
Verified
Journal Article
Closed access
HZHailin Zheng
Hailin Zheng
YHYun He
Yun He
XZXiaowei Zhou
Xiaowei Zhou
GQGuanyu Qian
Guanyu Qian
GLGuixia Lv
Guixia Lv
WLWeida Liu
Weida Liu

23 February 2021 in mSystems
Verified
Journal Article
Open access
PDF file
XZXiaowei Zhou
Xiaowei Zhou
NSNana Song
Nana Song
Dongmei LiDongmei Li
Dongmei Li
XLXiao-Fang Li
Xiao-Fang Li
WLWeida Liu
Weida Liu
C. albicans is a kind of pathogen of fungal infections that is found worldwide. Lysine crotonylation of proteins as a recently discovered PTM (posttranslational modification) may have a critical role in regulating cells.

15 November 2022 in Mycopathologia
Verified
Journal Article
Closed access
PDF file
SKSiyue Kan
Siyue Kan
NSNana Song
Nana Song
QPQiuyu Pang
Qiuyu Pang
HMHuan Mei
Huan Mei
HZHailin Zheng
Hailin Zheng
WLWeida Liu
Weida Liu

23 February 2021 in mSystems
Verified
Journal Article
Open access
PDF file
HZHailin Zheng
Hailin Zheng
NSNana Song
Nana Song
XZXiaowei Zhou
Xiaowei Zhou
HMHuan Mei
Huan Mei
Dongmei LiDongmei Li
Dongmei Li
WLWeida Liu
Weida Liu
C. albicans is one of the most commonly reported fungal pathogens in mucosal and systemic infections. A better understanding of its growth habits and metabolic processes in the host should help improve defense strategies.